DR info

Clinical trials : 206 / Drugs : 231 - (DrugBank : 28) / Drug target genes : 10 - Drug target pathways : 21

Autoimmune acquired coagulation factor deficiency and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability

ID	Diseases (Sorted by drug repositionability)
288	Autoimmune acquired coagulation factor deficiency
46	Malignant rheumatoid arthritis
96	Crohn disease
6	Parkinson disease
280	Huge arteriovenous malformation with cervicofacial or limb lesion
13	Multiple sclerosis/Neuromyelitis optica
11	Myasthenia gravis
70	Spinal stenosis
118	Myelomeningocele
169	Menkes disease
170	Occipital horn syndrome
206	Fragile X syndrome
113	Muscular dystrophy
17	Multiple system atrophy
86	Pulmonary arterial hypertension
323	Aromatic L-amino acid decarboxylase deficiency
2	Amyotrophic lateral sclerosis
22	Moyamoya disease
64	Thrombotic thrombocytopenic purpura
5	Progressive supranuclear palsy
8	Huntington disease
51	Scleroderma
210	Single Ventricle
67	Polycystic kidney disease
127	Frontotemporal lobar degeneration
271	Ankylosing spondylitis
107	Juvenile idiopathic arthritis
226	Interstitial cystitis with Hunners ulcer
28	Systemic amyloidosis
65	Primary immunodeficiency
215	Tetralogy of Fallot
299	Cystic fibrosis
85	Idiopathic interstitial pneumonia
49	Systemic lupus erythematosus
97	Ulcerative colitis
212	Tricuspid atresia
79	Homozygous familial hypercholesterolemia
57	Idiopathic dilated cardiomyopathy
66	IgA nephropathy
78	Hypopituitarism
63	Idiopathic thrombocytopenic purpura
58	Hypertrophic cardiomyopathy
90	Retinitis pigmentosa
72	Pituitary ADH secretion disorder
222	Primary nephrotic syndrome
75	Cushing disease
84	Sarcoidosis
34	Neurofibromatosis
317	Trifunctional protein deficiency
52	Mixed connective tissue disease
220	Rapidly progressive glomerulonephritis
30	Distal myopathy